Meyers AE - Search Results

1

Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.

Chege GK, Burgers WA, Stutz H, Meyers AE, Chapman R, Kiravu A, Bunjun R, Shephard EG, Jacobs WR Jr, Rybicki EP, Williamson AL. Chege GK, et al. Among authors: meyers ae. J Virol. 2013 May;87(9):5151-60. doi: 10.1128/JVI.03178-12. Epub 2013 Feb 28. J Virol. 2013. PMID: 23449790 Free PMC article.

2

Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles.

Halsey RJ, Tanzer FL, Meyers A, Pillay S, Lynch A, Shephard E, Williamson AL, Rybicki EP. Halsey RJ, et al. Virus Res. 2008 May;133(2):259-68. doi: 10.1016/j.virusres.2008.01.012. Epub 2008 Mar 10. Virus Res. 2008. PMID: 18329748

3

Expression of HIV-1 antigens in plants as potential subunit vaccines.

Meyers A, Chakauya E, Shephard E, Tanzer FL, Maclean J, Lynch A, Williamson AL, Rybicki EP. Meyers A, et al. BMC Biotechnol. 2008 Jun 23;8:53. doi: 10.1186/1472-6750-8-53. BMC Biotechnol. 2008. PMID: 18573204 Free PMC article.

4

HIV-1 subtype C Pr55gag virus-like particle vaccine efficiently boosts baboons primed with a matched DNA vaccine.

Chege GK, Shephard EG, Meyers A, van Harmelen J, Williamson C, Lynch A, Gray CM, Rybicki EP, Williamson AL. Chege GK, et al. J Gen Virol. 2008 Sep;89(Pt 9):2214-2227. doi: 10.1099/vir.0.83501-0. J Gen Virol. 2008. PMID: 18753231

5

A prime-boost immunisation regimen using recombinant BCG and Pr55(gag) virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons.

Chege GK, Thomas R, Shephard EG, Meyers A, Bourn W, Williamson C, Maclean J, Gray CM, Rybicki EP, Williamson AL. Chege GK, et al. Vaccine. 2009 Jul 30;27(35):4857-66. doi: 10.1016/j.vaccine.2009.05.064. Epub 2009 Jun 9. Vaccine. 2009. PMID: 19520196

6

Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system.

Pillay S, Meyers A, Williamson AL, Rybicki EP. Pillay S, et al. Biotechnol Prog. 2009 Jul-Aug;25(4):1153-60. doi: 10.1002/btpr.187. Biotechnol Prog. 2009. PMID: 19572400

7

HIV-1 sub-type C chimaeric VLPs boost cellular immune responses in mice.

Pillay S, Shephard EG, Meyers AE, Williamson AL, Rybicki EP. Pillay S, et al. Among authors: meyers ae. J Immune Based Ther Vaccines. 2010 Nov 19;8:7. doi: 10.1186/1476-8518-8-7. J Immune Based Ther Vaccines. 2010. PMID: 21087527 Free PMC article.

8

Vaccine farming in Cape Town.

Rybicki EP, Williamson AL, Meyers A, Hitzeroth II. Rybicki EP, et al. Hum Vaccin. 2011 Mar;7(3):339-48. doi: 10.4161/hv.7.3.14263. Epub 2011 Mar 1. Hum Vaccin. 2011. PMID: 21358269 Review.

9

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs.

Valley-Omar Z, Meyers AE, Shephard EG, Williamson AL, Rybicki EP. Valley-Omar Z, et al. Among authors: meyers ae. Virol J. 2011 Oct 6;8:462. doi: 10.1186/1743-422X-8-462. Virol J. 2011. PMID: 21975161 Free PMC article.

10

Stability studies of HIV-1 Pr55gag virus-like particles made in insect cells after storage in various formulation media.

Lynch A, Meyers AE, Williamson AL, Rybicki EP. Lynch A, et al. Among authors: meyers ae. Virol J. 2012 Sep 18;9:210. doi: 10.1186/1743-422X-9-210. Virol J. 2012. PMID: 22988963 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters